Assay Detects Fish Trematode DNA in Human Stools
By LabMedica International staff writers Posted on 13 Jul 2017 |
Image: A light microscopy of an egg of Amphimerus sp. observed in a fecal specimen from Ecuador, almost indistinguishable from some other liver fluke eggs (Photo courtesy of Universidad Central del Ecuador).
Amphimeriasis is a fish-borne disease caused by the liver fluke Amphimerus spp. that has recently been reported as endemic in the tropical Pacific side of Ecuador with a high prevalence in humans and domestic animals.
The diagnosis of Amphimeriasis is based on the stool examination to identify parasite eggs, but it lacks sensitivity. Additionally, the morphology of the eggs may be confounded with other liver and intestinal flukes and no immunological or molecular methods have been developed to date.
Scientists at the Universidad Central del Ecuador (Quito, Ecuador) and their colleagues obtained human stool samples from indigenous communities during February 2016. The samples were processed for parasitological screening under light microscopy by direct examination, simple sedimentation, formalin-ether concentration and Kato-Katz techniques. After parasitological screening, a total of 44 stool samples were selected, including 25 (56.81%) that were positive for Amphimerus sp. eggs-by one or more parasitological methods-and 19 (43.18%) negative samples.
DNA extraction was performed using the Mini Stool DNA Extraction kit. To determine the specificity of polymerase chain reaction (PCR) and loop-mediated isothermal amplification (LAMP) assays to amplify only Amphimerus sp. DNA, a total of 16 DNA samples from several helminths, including trematodes, cestodes, nematodes and protozoa were used. DNA was measured using a Nanodrop ND-100 spectrophotometer. The LAMP assay was called LAMPhimerus.
The team obtained from the total of 25 parasitologically positive stool samples, 9/25 (36%) and 18/25 (72%) positive results when they applied LAMPhimerus for 60 min and 120 min, respectively. Additionally, positive results included 5/19 (26.3%) samples that were negative in all previously applied parasitological tests. Of the 11 that were simultaneously positive on three parasitological tests 82% were also positive on the LAMP assay; only the two samples, with the same very low egg count, were negative on the LAMP assay.
The authors have developed, for the first time, a LAMP assay (namely, LAMPhimerus) for the sensitive and specific detection of Amphimerus sp. DNA in human stool samples. After further studies for validation, the method could be readily adapted for effective field diagnosis and disease surveillance in amphimeriasis-endemic areas. The study was published on June 19, 2017, in the journal Public Library of Science Neglected Tropical Diseases.
Related Links:
Universidad Central del Ecuador
The diagnosis of Amphimeriasis is based on the stool examination to identify parasite eggs, but it lacks sensitivity. Additionally, the morphology of the eggs may be confounded with other liver and intestinal flukes and no immunological or molecular methods have been developed to date.
Scientists at the Universidad Central del Ecuador (Quito, Ecuador) and their colleagues obtained human stool samples from indigenous communities during February 2016. The samples were processed for parasitological screening under light microscopy by direct examination, simple sedimentation, formalin-ether concentration and Kato-Katz techniques. After parasitological screening, a total of 44 stool samples were selected, including 25 (56.81%) that were positive for Amphimerus sp. eggs-by one or more parasitological methods-and 19 (43.18%) negative samples.
DNA extraction was performed using the Mini Stool DNA Extraction kit. To determine the specificity of polymerase chain reaction (PCR) and loop-mediated isothermal amplification (LAMP) assays to amplify only Amphimerus sp. DNA, a total of 16 DNA samples from several helminths, including trematodes, cestodes, nematodes and protozoa were used. DNA was measured using a Nanodrop ND-100 spectrophotometer. The LAMP assay was called LAMPhimerus.
The team obtained from the total of 25 parasitologically positive stool samples, 9/25 (36%) and 18/25 (72%) positive results when they applied LAMPhimerus for 60 min and 120 min, respectively. Additionally, positive results included 5/19 (26.3%) samples that were negative in all previously applied parasitological tests. Of the 11 that were simultaneously positive on three parasitological tests 82% were also positive on the LAMP assay; only the two samples, with the same very low egg count, were negative on the LAMP assay.
The authors have developed, for the first time, a LAMP assay (namely, LAMPhimerus) for the sensitive and specific detection of Amphimerus sp. DNA in human stool samples. After further studies for validation, the method could be readily adapted for effective field diagnosis and disease surveillance in amphimeriasis-endemic areas. The study was published on June 19, 2017, in the journal Public Library of Science Neglected Tropical Diseases.
Related Links:
Universidad Central del Ecuador
Latest Molecular Diagnostics News
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
- Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
- Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
- Low-Cost Point-Of-Care Diagnostic to Expand Access to STI Testing
- 18-Gene Urine Test for Prostate Cancer to Help Avoid Unnecessary Biopsies
- Urine-Based Test Detects Head and Neck Cancer
- Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer
- Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer
- Simple PCR Assay Accurately Differentiates Between Small Cell Lung Cancer Subtypes
- Revolutionary T-Cell Analysis Approach Enables Cancer Early Detection
- Single Genetic Test to Accelerate Diagnoses for Rare Developmental Disorders